Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2022 | How the role of transplant in ALL is evolving with the introduction of novel immunotherapies

Josep-Maria Ribera • 4 Oct 2022
SOHO 2022
Acute Lymphoblastic Leukemia Leukemia Antibodies CAR-T

In this video, Josep-Maria Ribera, MD, PhD, University of Barcelona, Barcelona, Spain, shares some insights into how the role of stem cell transplantation is constantly evolving in acute lymphoblastic leukemia (ALL) with the use of novel immunotherapies, including monoclonal antibodies and CAR-T cell therapy. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Josep-Maria Ribera

1:25
BURKIMAB14: dose reduction of chemotherapy in young adults with Burkitt lymphoma
Josep-Maria Ribera • 9 Jun 2023
0:55
PhALLCON: Phase III study of ponatinib vs imatinib in newly diagnosed Ph+ ALL
Josep-Maria Ribera • 9 Jun 2023
1:02
Incorporating immunotherapy into the first-line treatment of ALL
Josep-Maria Ribera • 9 Jun 2023
1:31
PETHEMA LAL19: continuation therapy or allogeneic transplantation according to MRD & genetics in ALL
Josep-Maria Ribera • 8 Oct 2022

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals